Match tier
Listed
Presence
Current · Arkansas
Last published
2023
Sources
OpenAlex · ORCID
Refreshed
2026-10-03
J
John W. Theus
UAMS Contingent Worker
Also affiliated: American Red Cross (2012); Central Arkansas Veterans Healthcare System (2009–2023); National Heart, Lung, and Blood Institute (2009)
LPSL Lab & Pathology, College of Integrated Clinical Enterprise
8 h-index
18 pubs
252 cited
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
John Theus's research has focused on the immune response, particularly concerning tumor necrosis factor-alpha and its role in conditions such as uterine cervical neoplasms and mycobacterial infections. His work has also extended to examining hematopoietic stem cells and platelet function, with an interest in fetal blood. Recently, Theus has contributed to studies on SARS-CoV-2 infection, including antibody testing in healthcare workers. He has authored 18 publications with 249 citations and an h-index of 8. Theus collaborates with Thaddeus Bartter, Anita Joshi, and Manish Joshi, all from the University of Arkansas for Medical Sciences, with whom he shares two publications each.
Metrics
- h-index: 8
- Publications: 18
- Citations: 252
Positions
-
UAMS Contingent Worker publications 1995–2023University of Arkansas for Medical Sciences LPSL Lab & Pathology, College of Integrated Clinical Enterprise Institutional directory
Selected Publications
-
COVID-19 Antibody Testing in Healthcare Workers in Arkansas (2023)
-
Red blood cell transfusion: Impact of an education program and a clinical guideline on transfusion practice (2014)
-
Chemotherapy Does Not Enhance CD34+ Cell Collection When Added to Growth Factor and Plerixafor in Patients Who Are Poor Mobilizers (2011)
-
Viability and engraftment of hematopoietic progenitor cells after long-term cryopreservation: effect of diagnosis and percentage dimethyl sulfoxide concentration (2010)
-
A comparison of washed and volume‐reduced platelets with respect to platelet activation, aggregation, and plasma protein removal (2010)
-
A 15 Hour Dosing-Collection Interval for Plerixafor Is at Least as Effective as the Standard 10 Hour Interval. (2009)
-
Viability and Engraftment of Hematopoietic Progenitor Cells (HPC) After Long Term Cryopreservation: Effect of Diagnosis and % Dimethylsulfoxide (DMSO) Concentration. (2009)
-
Comparison of Bromcresol Purple and Capillary Protein Electrophoresis for Quantification of Serum Albumin in Multiple Myeloma (2009)
-
UC blood infection with clinical strains of Mycobacterium tuberculosis: a novel model (2007)
-
Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion costimulation molecules ICAM-1 in human cervical cancer (1997)
-
Localized subclinical radiation enteropathy prolongs intestinal transit time: An experimental study in a rat model (1995)
Collaboration Network
Top Collaborators
Michele Cottler‐Fox
University of Arkansas for Medical Sciences
6 shared publications
In database
- A comparison of washed and volume‐reduced platelets with respect to platelet activation, aggregation, and plasma protein removal
- Viability and engraftment of hematopoietic progenitor cells after long-term cryopreservation: effect of diagnosis and percentage dimethyl sulfoxide concentration
- UC blood infection with clinical strains of Mycobacterium tuberculosis: a novel model
- A 15 Hour Dosing-Collection Interval for Plerixafor Is at Least as Effective as the Standard 10 Hour Interval.
- Chemotherapy Does Not Enhance CD34+ Cell Collection When Added to Growth Factor and Plerixafor in Patients Who Are Poor Mobilizers
Showing 5 of 6 shared publications
Gina Pesek
University of Arkansas for Medical Sciences (US)
5 shared publications
- A comparison of washed and volume‐reduced platelets with respect to platelet activation, aggregation, and plasma protein removal
- Viability and engraftment of hematopoietic progenitor cells after long-term cryopreservation: effect of diagnosis and percentage dimethyl sulfoxide concentration
- A 15 Hour Dosing-Collection Interval for Plerixafor Is at Least as Effective as the Standard 10 Hour Interval.
- Chemotherapy Does Not Enhance CD34+ Cell Collection When Added to Growth Factor and Plerixafor in Patients Who Are Poor Mobilizers
- Viability and Engraftment of Hematopoietic Progenitor Cells (HPC) After Long Term Cryopreservation: Effect of Diagnosis and % Dimethylsulfoxide (DMSO) Concentration.
Bart Barlogie
University of Arkansas for Medical Sciences
4 shared publications
In database
- Viability and engraftment of hematopoietic progenitor cells after long-term cryopreservation: effect of diagnosis and percentage dimethyl sulfoxide concentration
- A 15 Hour Dosing-Collection Interval for Plerixafor Is at Least as Effective as the Standard 10 Hour Interval.
- Chemotherapy Does Not Enhance CD34+ Cell Collection When Added to Growth Factor and Plerixafor in Patients Who Are Poor Mobilizers
- Viability and Engraftment of Hematopoietic Progenitor Cells (HPC) After Long Term Cryopreservation: Effect of Diagnosis and % Dimethylsulfoxide (DMSO) Concentration.
Muthu Veeraputhiran
University of Arkansas for Medical Sciences
3 shared publications
In database
- A comparison of washed and volume‐reduced platelets with respect to platelet activation, aggregation, and plasma protein removal
- Viability and engraftment of hematopoietic progenitor cells after long-term cryopreservation: effect of diagnosis and percentage dimethyl sulfoxide concentration
- Viability and Engraftment of Hematopoietic Progenitor Cells (HPC) After Long Term Cryopreservation: Effect of Diagnosis and % Dimethylsulfoxide (DMSO) Concentration.
Mayumi Nakagawa
University of Arkansas for Medical Sciences
3 shared publications
In database
- A comparison of washed and volume‐reduced platelets with respect to platelet activation, aggregation, and plasma protein removal
- A 15 Hour Dosing-Collection Interval for Plerixafor Is at Least as Effective as the Standard 10 Hour Interval.
- Chemotherapy Does Not Enhance CD34+ Cell Collection When Added to Growth Factor and Plerixafor in Patients Who Are Poor Mobilizers
Joshua A. Bornhorst
University of Arkansas for Medical Sciences (US)
2 shared publications
- A comparison of washed and volume‐reduced platelets with respect to platelet activation, aggregation, and plasma protein removal
- Comparison of Bromcresol Purple and Capillary Protein Electrophoresis for Quantification of Serum Albumin in Multiple Myeloma
Eric Rosenbaum
University of Arkansas for Medical Sciences
2 shared publications
In database
- A 15 Hour Dosing-Collection Interval for Plerixafor Is at Least as Effective as the Standard 10 Hour Interval.
- Chemotherapy Does Not Enhance CD34+ Cell Collection When Added to Growth Factor and Plerixafor in Patients Who Are Poor Mobilizers
Howard L. Corwin
University of Arkansas for Medical Sciences (US)
1 shared publication
- Red blood cell transfusion: Impact of an education program and a clinical guideline on transfusion practice
Christopher Cargile
University of Arkansas for Medical Sciences
1 shared publication
In database
- Red blood cell transfusion: Impact of an education program and a clinical guideline on transfusion practice
Nicholas P. Lang
University of Arkansas for Medical Sciences (US)
1 shared publication
- Red blood cell transfusion: Impact of an education program and a clinical guideline on transfusion practice
Jerry Ware
University of Arkansas for Medical Sciences
1 shared publication
In database
- A comparison of washed and volume‐reduced platelets with respect to platelet activation, aggregation, and plasma protein removal
Judith Dent
University of Arkansas for Medical Sciences (US)
1 shared publication
- A comparison of washed and volume‐reduced platelets with respect to platelet activation, aggregation, and plasma protein removal
Ginell R. Post
University of Arkansas for Medical Sciences
1 shared publication
In database
- A comparison of washed and volume‐reduced platelets with respect to platelet activation, aggregation, and plasma protein removal
Martin Hauer‐Jensen
University of Arkansas for Medical Sciences
1 shared publication
In database
- Localized subclinical radiation enteropathy prolongs intestinal transit time: An experimental study in a rat model
Jeffrey D. Bradley
University of Arkansas for Medical Sciences (US)
1 shared publication
- Localized subclinical radiation enteropathy prolongs intestinal transit time: An experimental study in a rat model
Similar Researchers
Based on overlapping research topics
Jennifer Chen
University of Arkansas at Fayetteville
Immune Response and Inflammation
Host-Pathogen Interactions
SARS-CoV-2 and COVID-19 Research
Prisha Warikoo
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Host-Pathogen Interactions
SARS-CoV-2 and COVID-19 Research
Zijing Zhang
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Host-Pathogen Interactions
SARS-CoV-2 and COVID-19 Research
J. Craig Forrest
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Host-Pathogen Interactions
SARS-CoV-2 and COVID-19 Research
Karl W. Boehme
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Host-Pathogen Interactions
SARS-CoV-2 and COVID-19 Research
Tahseen Raza
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Host-Pathogen Interactions
Cancer-related molecular mechanisms research